Ambu exits Russia

The Danish medtech company is currently in a process of withdrawing from its Russian activities, but has left several questions about its organization there go unanswered.

Going forward, Ambu will no longer have a presence in Russia | Photo: Pr / Ambu

The Russian market is no longer a place where Ambu wants to operate, and the medtech company is therefore shutting down its activities in the country.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs